CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-10 | Chrousos Phaedra Director | Grant or award | +5,000 | 15,000 | ||
| 2021-06-10 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-03-15 | Jones Aranthan II Chief Corp. Affairs Officer | Option exercise | +15,000 | $11.32 | $170K | 111,935 |
| 2021-03-15 | Jones Aranthan II Chief Corp. Affairs Officer | Sale | −18,000 | $17.72 | $319K | 93,935 |
| 2021-03-15 | Jones Aranthan II Chief Corp. Affairs Officer | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 55,000 | ||
| 2021-03-08 | Polymeropoulos Mihael Hristos President and CEO | Sale | −175,000 | $18.00 | $3.2M | 1,221,062 |
| 2021-03-05 | Williams Timothy SVP & General Counsel | Sale | −200 | $17.88 | $4K | 92,326 |
| 2021-03-05 | Williams Timothy SVP & General Counsel | Sale | −5,400 | $17.85 | $96K | 86,926 |
| 2021-03-02 | Williams Timothy SVP & General Counsel | Sale | −7,674 | $18.54 | $142K | 92,526 |
| 2021-03-02 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −3,888 | $18.45 | $72K | 78,202 |
| 2021-03-02 | Polymeropoulos Mihael Hristos President and CEO | Sale | −15,206 | $18.34 | $279K | 1,396,062 |
| 2021-03-02 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −6,044 | $18.23 | $110K | 101,426 |
| 2021-03-02 | Jones Aranthan II Chief Corp. Affairs Officer | Sale | −3,865 | $18.04 | $70K | 96,935 |
| 2021-03-02 | Birznieks Gunther SVP, Business Development | Sale | −16,620 | $18.19 | $302K | 171,708 |
| 2021-03-01 | Williams Timothy SVP & General Counsel | Sale | −11,856 | $18.60 | $221K | 100,200 |
| 2021-03-01 | Polymeropoulos Mihael Hristos President and CEO | Sale | −7,479 | $18.45 | $138K | 1,411,268 |
| 2021-03-01 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −3,327 | $18.57 | $62K | 107,470 |
| 2021-03-01 | Birznieks Gunther SVP, Business Development | Sale | −3,845 | $18.66 | $72K | 188,328 |
| 2021-02-24 | Williams Timothy SVP & General Counsel | Grant or award | +32,700 | 112,056 | ||
| 2021-02-24 | Williams Timothy SVP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +77,500 | 77,500 |
Page 11 of 20 · 387 trades